beta-lactams has been researched along with Opportunistic Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sick, AC; Tamma, PD; Tschudin-Sutter, S; Turnbull, AE; Weissman, SJ | 1 |
| Hasegawa, Y; Hatakeyama, K; Kawamura, I; Kojima, S; Ohkura, T; Ohkusu, K; Takahashi, Y; Yagi, T | 1 |
| Cuenca, M; de Górgolas, M; Fernández Guerrero, ML; Fernández Roblas, R; Marrero, J; Ramos, JM | 1 |
| Darbas, H; Diego, I; Gouby, A; Jean-Pierre, H; Jeannot, JL; Jumas-Bilak, E; Marchandin, H; Teyssier, C | 1 |
| Corkill, JE; Deveney, J; Hart, CA; Heaf, D; Pratt, J; Shears, P; Smyth, A | 1 |
| Dejace, P; Klastersky, J | 1 |
1 review(s) available for beta-lactams and Opportunistic Infections
| Article | Year |
|---|---|
[A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Drug Therapy, Combination; Humans; Opportunistic Infections | 1987 |
5 other study(ies) available for beta-lactams and Opportunistic Infections
| Article | Year |
|---|---|
Empiric combination therapy for gram-negative bacteremia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Baltimore; beta-Lactams; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empiricism; Female; Gram-Negative Bacterial Infections; Humans; Infant; Kaplan-Meier Estimate; Male; Neutropenia; Odds Ratio; Opportunistic Infections; Propensity Score; Retrospective Studies; Survival Analysis | 2014 |
Recurrent vascular catheter-related bacteremia caused by Delftia acidovorans with different antimicrobial susceptibility profiles.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Catheter-Related Infections; Catheters, Indwelling; Child; Delftia acidovorans; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests; Neuroblastoma; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; RNA, Ribosomal, 16S | 2011 |
Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae | 2003 |
Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Colistin; Culture Media; DNA, Bacterial; DNA, Ribosomal; Fermentation; Gentian Violet; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Netilmicin; Ochrobactrum; Opportunistic Infections; Oxidoreductases; Phenazines; Ribotyping; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Temperature; Tobramycin; Urease | 2005 |
Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamase Inhibitors; beta-Lactams; Burkholderia cepacia; Carbon Dioxide; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Opportunistic Infections; Pseudomonas Infections; Sputum | 1994 |